Cosmo Pharmaceuticals N.V.

SWX:COPN Stock Report

Market Cap: CHF 985.2m

Cosmo Pharmaceuticals Dividends and Buybacks

Dividend criteria checks 4/6

Cosmo Pharmaceuticals is a dividend paying company with a current yield of 3.03% that is well covered by earnings.

Key information

3.0%

Dividend yield

0.1%

Buyback Yield

Total Shareholder Yield3.2%
Future Dividend Yield1.4%
Dividend Growth16.3%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareCHF 2.000
Payout ratio46%

Recent dividend and buyback updates

Recent updates

Cosmo Pharmaceuticals N.V.'s (VTX:COPN) P/S Still Appears To Be Reasonable

Nov 22
Cosmo Pharmaceuticals N.V.'s (VTX:COPN) P/S Still Appears To Be Reasonable

Market Participants Recognise Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Revenues

May 02
Market Participants Recognise Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Revenues

Cosmo Pharmaceuticals' (VTX:COPN) Weak Earnings May Only Reveal A Part Of The Whole Picture

Mar 28
Cosmo Pharmaceuticals' (VTX:COPN) Weak Earnings May Only Reveal A Part Of The Whole Picture

Broker Revenue Forecasts For Cosmo Pharmaceuticals N.V. (VTX:COPN) Are Surging Higher

Mar 26
Broker Revenue Forecasts For Cosmo Pharmaceuticals N.V. (VTX:COPN) Are Surging Higher

Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Popularity With Investors Is Clear

Dec 01
Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Popularity With Investors Is Clear

Earnings Beat: Cosmo Pharmaceuticals N.V. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jul 29
Earnings Beat: Cosmo Pharmaceuticals N.V. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

We Think Cosmo Pharmaceuticals (VTX:COPN) Can Stay On Top Of Its Debt

Nov 24
We Think Cosmo Pharmaceuticals (VTX:COPN) Can Stay On Top Of Its Debt

Cosmo Pharmaceuticals' (VTX:COPN) Solid Profits Have Weak Fundamentals

Mar 31
Cosmo Pharmaceuticals' (VTX:COPN) Solid Profits Have Weak Fundamentals

These 4 Measures Indicate That Cosmo Pharmaceuticals (VTX:COPN) Is Using Debt Reasonably Well

Aug 02
These 4 Measures Indicate That Cosmo Pharmaceuticals (VTX:COPN) Is Using Debt Reasonably Well

Increases to CEO Compensation Might Be Put On Hold For Now at Cosmo Pharmaceuticals N.V. (VTX:COPN)

May 20
Increases to CEO Compensation Might Be Put On Hold For Now at Cosmo Pharmaceuticals N.V. (VTX:COPN)

Cosmo Pharmaceuticals (VTX:COPN) Seems To Use Debt Quite Sensibly

Apr 03
Cosmo Pharmaceuticals (VTX:COPN) Seems To Use Debt Quite Sensibly

When Can We Expect A Profit From Cosmo Pharmaceuticals N.V. (VTX:COPN)?

Mar 07
When Can We Expect A Profit From Cosmo Pharmaceuticals N.V. (VTX:COPN)?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: COPN's dividend payments have been volatile in the past 10 years.

Growing Dividend: COPN's dividend payments have increased over the past 10 years.


Dividend Yield vs Market

Cosmo Pharmaceuticals Dividend Yield vs Market
How does COPN dividend yield compare to the market?
SegmentDividend Yield
Company (COPN)3.0%
Market Bottom 25% (CH)2.0%
Market Top 25% (CH)4.3%
Industry Average (Pharmaceuticals)2.5%
Analyst forecast (COPN) (up to 3 years)1.4%

Notable Dividend: COPN's dividend (3.03%) is higher than the bottom 25% of dividend payers in the Swiss market (2%).

High Dividend: COPN's dividend (3.03%) is low compared to the top 25% of dividend payers in the Swiss market (4.34%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (46.2%), COPN's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (32.8%), COPN's dividend payments are well covered by cash flows.


Discover strong dividend paying companies